Computed Tomography Screening for Early Lung Cancer, COPD and Cardiovascular Disease in Shanghai: Rationale and Design of a Population-based Comparative Study.

Academic Radiology
Yihui DuShi-Yuan Liu

Abstract

To describe the rational and design of a population-based comparative study. The objective of the study is to assess the screening performance of volume-based management of CT-detected lung nodule in comparison to diameter-based management, and to improve the effectiveness of CT screening for chronic obstructive pulmonary disease (COPD) and cardiovascular disease (CVD), in addition to lung cancer, based on quantitative measurement of CT imaging biomarkers in a Chinese screening setting. A population-based comparative study is being performed, including 10,000 asymptomatic participants between 40 and 74 years old from Shanghai urban population. Participants in the intervention group undergo a low-dose chest and cardiac CT scan at baseline and 1 year later, and are managed according to NELCIN-B3 protocol. Participants in the control group undergo a low-dose chest CT scan according to the routine CT protocol and are managed according to the clinical practice. Epidemiological data are collected through questionnaires. In the fourth year from baseline, the diagnosis of the three diseases will be collected. The unnecessary referral rate will be compared between NELCIN-B3 and standard protocol for managing early-detected lung nodules....Continue Reading

References

Oct 18, 2003·American Heart Journal·Jay N CohnNatalia Florea
Dec 7, 2005·Respiration; International Review of Thoracic Diseases·David B PriceConstant P van Schayck
Mar 28, 2008·The New England Journal of Medicine·Robert DetranoRichard A Kronmal
Jul 1, 2011·The New England Journal of Medicine·UNKNOWN National Lung Screening Trial Research TeamJoRean D Sicks
Oct 27, 2011·JAMA : the Journal of the American Medical Association·Onno M MetsPim A de Jong
May 23, 2012·JAMA : the Journal of the American Medical Association·Peter B BachFrank C Detterbeck
Apr 6, 2016·JAMA : the Journal of the American Medical Association·UNKNOWN US Preventive Services Task Force (USPSTF)Michael P Pignone
Apr 21, 2016·International Journal for Equity in Health·Wen LiuShixue Li
May 20, 2016·Annals of Translational Medicine·Jessica GonzalezJavier J Zulueta
Jan 28, 2017·American Journal of Respiratory and Critical Care Medicine·Claus F VogelmeierAlvar Agustí
Dec 7, 2017·The Lancet Oncology·Matthijs OudkerkJohn K Field
Apr 14, 2018·The Lancet. Respiratory Medicine·Liwen FangLinhong Wang
May 23, 2018·International Journal of Environmental Research and Public Health·Jibin TanMaigeng Zhou
Dec 18, 2018·Academic Radiology·Li FanShi-Yuan Liu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.